Results 31 to 40 of about 14,162 (232)

Epidemiology of hidradenitis suppurativa in Poland in relation to international data

Przegląd Dermatologiczny, 2017
Hidradenitis suppurativa (acne inversa) is a chronic, inflammatory, recurrent, debilitating disease of hair follicles manifested by painful, deepseated, inflamed lesions localized in intertriginous areas.
Łukasz Matusiak, Andrzej Kaszuba, Dorota Krasowska, Waldemar Placek, Jacek Szepietowski   +4 more
doaj   +1 more source

Consensus on the treatment of hidradenitis suppurativa - Brazilian Society of Dermatology [PDF]

Anais Brasileiros de Dermatologia, 2019
: Hidradenitis suppurativa is a chronic immune mediated disease of universal distribution that causes great damage to the quality of life of the affected individual, whose prevalence is estimated at 0.41% in the Brazilian population.
Renata Ferreira Magalhães, Maria Cecília Rivitti-Machado, Gleison Vieira Duarte, Roberto Souto, Daniel Holthausen Nunes, Mario Chaves, Sérgio Henrique Hirata, Andrea Machado Coelho Ramos   +7 more
doaj   +1 more source

Incidence, Risk Factors, and Prognosis of Hidradenitis Suppurativa Across the Globe: Insights from the Literature

Clinical, Cosmetic and Investigational Dermatology, 2023
Hend M Alotaibi Dermatology Department, College of Medicine, King Saud University, Riyadh, Kingdom of Saudi ArabiaCorrespondence: Hend M Alotaibi, Dermatology department, College of medicine, King Saud University, Riyadh, Kingdom of Saudi Arabia, Tel ...
Alotaibi HM
doaj  

Efficacy of Ritlecitinib for Vitiligo Treatment Stratified by Baseline Demographic and Clinical Characteristics: Post Hoc Analysis of a Phase 2b Study

JEADV Clinical Practice, EarlyView.
This post hoc analysis examined the efficacy of ritlecitinib in subgroups of patients with vitiligo, defined by demographic and clinical characteristics. Patients completed the dose‐ranging and extension periods of the phase 2b study (NCT03715829) of ritlecitinib.
A. G. Pandya, I. Hamzavi, P. Ghosh, K. Ezzedine, J. E. Harris, R. Adiri, S. Chen, E. Peeva, Y. Yamaguchi   +8 more
wiley   +1 more source

Metascoring Hidradenitis suppurativa

Journal of the European Academy of Dermatology and Venereology, 2020
info:eu-repo/semantics ...
M. Daoud, H. Njimi, F. Benhadou, M. Suppa, M. Daxhelet, J. Karama, J. White, G.B.E. Jemec, V. del Marmol   +8 more
openaire   +4 more sources

Hidradenitis suppurativa with SAPHO syndrome maintained effectively with adalimumab, methotrexate, and intralesional corticosteroid injections

SAGE Open Medical Case Reports, 2018
Introduction: Hidradenitis suppurativa and synovitis, acne, pustulosis, hyperostosis, osteitis syndrome are chronic, debilitating diseases involving apocrine gland-bearing skin inflammation and bone inflammation, respectively. Although both often present
Erika L Crowley, Ashley O’Toole, Melinda J Gooderham   +2 more
doaj   +1 more source

Leflunomide-Induced Hidradenitis Suppurativa

Case Reports in Rheumatology, 2020
Hidradenitis suppurativa is an inflammatory disease of the pilosebaceous unit with a chronic intermittent course and a devastating effect on quality of life. Rare reports of drug-induced hidradenitis suppurativa exist.
Achraf Machan, Hasna Azendour, Hamza Toufik, Lahsen Achemlal, Mohammed Boui, Naoufal Hjira   +5 more
doaj   +1 more source

Surgical Procedures and Medical Treatments Among Patients With Hidradenitis Suppurativa Before and After Referral to Specialised Dermatological Hospital Care: A Nationwide Registry Study

JEADV Clinical Practice, EarlyView.
Hidradenitis suppurativa (HS) is often diagnosed late, complicating management. In this nationwide Danish study including 10,196 patients with dermatologist‐verified HS, we examined treatment patterns before and after referral to specialised hospital care.
Nana A. L. Rosenø, Nadja Højgaard Pedersen, Yvonne Geissbühler, Nikolaj Holgersen, Valdemar Wendelboe Nielsen, Jacob P. Thyssen, Alexander Egeberg, Hans Christian Ring, Simon Francis Thomsen   +8 more
wiley   +1 more source

Clinical Implementation of Biologics and Small Molecules in the Treatment of Hidradenitis Suppurativa [PDF]

, 2021
Pim Aarts, Koen Dudink, Allard R.J.V. Vossen, Kelsey R. van Straalen, Christine B. Ardon, Errol P. Prens, Hessel H. van der Zee   +6 more
openalex   +1 more source

Assessing the Effect of Adalimumab in Granuloma Annulare: A Case Series and Literature Review

JEADV Clinical Practice, EarlyView.
ABSTRACT Granuloma annulare (GA) is a benign granulomatous skin disorder for which standardized treatment guidelines are lacking due to limited evidence. Adalimumab, a TNF‐α inhibitor, shows promise as a therapeutic option due to its potential to disrupt GA granulomas.
Adriana Caixinha Valorenzos, Line Kibsgaard, Trine Bertelsen   +2 more
wiley   +1 more source